Literature DB >> 24193547

Novel bone endocrine networks integrating mineral and energy metabolism.

Min Pi1, L Darryl Quarles.   

Abstract

The skeleton is an endocrine organ that regulates energy metabolism through the release of the osteoblast-derived hormone, osteocalcin (Ocn), and phosphate and vitamin D homeostasis through the secretion by osteoblasts and osteocytes of the novel hormone, FGF23 Ocn activates a widely expressed G-protein coupled receptor, GPRC6A, to regulate insulin secretion by pancreatic β-cells, testosterone secretion by testicular Leydig cells, fatty acid metabolism in the liver, and insulin sensitivity of muscle and fat, as well as other functions. FGF23 targets a limited number of tissues, including kidney, parathyroid gland, choroid plexus, and pituitary gland that co-express FGF receptors and α-Klotho complexes. Ectodomain shedding and secretion of a soluble form of Klotho also is purported to act as an anti-ageing hormone. Further elucidation of these novel endocrine networks is likely to lead to new appreciation of the cooperation between various organ systems to regulate phosphate, vitamin D, and energy metabolism.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24193547      PMCID: PMC4011556          DOI: 10.1007/s11914-013-0178-8

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  94 in total

1.  FGF23 induces left ventricular hypertrophy.

Authors:  Christian Faul; Ansel P Amaral; Behzad Oskouei; Ming-Chang Hu; Alexis Sloan; Tamara Isakova; Orlando M Gutiérrez; Robier Aguillon-Prada; Joy Lincoln; Joshua M Hare; Peter Mundel; Azorides Morales; Julia Scialla; Michael Fischer; Elsayed Z Soliman; Jing Chen; Alan S Go; Sylvia E Rosas; Lisa Nessel; Raymond R Townsend; Harold I Feldman; Martin St John Sutton; Akinlolu Ojo; Crystal Gadegbeku; Giovana Seno Di Marco; Stefan Reuter; Dominik Kentrup; Klaus Tiemann; Marcus Brand; Joseph A Hill; Orson W Moe; Makoto Kuro-O; John W Kusek; Martin G Keane; Myles Wolf
Journal:  J Clin Invest       Date:  2011-10-10       Impact factor: 14.808

2.  GPRC6A mediates responses to osteocalcin in β-cells in vitro and pancreas in vivo.

Authors:  Min Pi; Yunpeng Wu; L Darryl Quarles
Journal:  J Bone Miner Res       Date:  2011-07       Impact factor: 6.741

3.  GPRC6A regulates prostate cancer progression.

Authors:  Min Pi; L Darryl Quarles
Journal:  Prostate       Date:  2011-06-16       Impact factor: 4.104

4.  (1-34) Parathyroid hormone infusion acutely lowers fibroblast growth factor 23 concentrations in adult volunteers.

Authors:  Orlando M Gutiérrez; Kelsey T Smith; Allison Barchi-Chung; Neha M Patel; Tamara Isakova; Myles Wolf
Journal:  Clin J Am Soc Nephrol       Date:  2012-01       Impact factor: 8.237

5.  Evidence that conditionally immortalized human osteoblasts express an osteocalcin receptor.

Authors:  P V Bodine; B S Komm
Journal:  Bone       Date:  1999-11       Impact factor: 4.398

Review 6.  Regulation and function of the FGF23/klotho endocrine pathways.

Authors:  Aline Martin; Valentin David; L Darryl Quarles
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

7.  Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice.

Authors:  Mathieu Ferron; Marc D McKee; Robert L Levine; Patricia Ducy; Gérard Karsenty
Journal:  Bone       Date:  2011-04-29       Impact factor: 4.398

8.  Relationship of testosterone and osteocalcin levels during growth.

Authors:  Salman Kirmani; Elizabeth J Atkinson; L Joseph Melton; B Lawrence Riggs; Shreyasee Amin; Sundeep Khosla
Journal:  J Bone Miner Res       Date:  2011-09       Impact factor: 6.741

Review 9.  The contribution of bone to whole-organism physiology.

Authors:  Gérard Karsenty; Mathieu Ferron
Journal:  Nature       Date:  2012-01-18       Impact factor: 69.504

10.  Fibroblast growth factor 23 (FGF23) and alpha-klotho stimulate osteoblastic MC3T3.E1 cell proliferation and inhibit mineralization.

Authors:  V Shalhoub; S C Ward; B Sun; J Stevens; L Renshaw; N Hawkins; W G Richards
Journal:  Calcif Tissue Int       Date:  2011-06-03       Impact factor: 4.333

View more
  15 in total

1.  Fibroblast Growth Factor 23 is Associated With Adiposity in Patients Receiving Hemodialysis: Possible Cross Talk Between Bone and Adipose Tissue.

Authors:  Janet M Chiang; George A Kaysen; Anne L Schafer; Cynthia Delgado; Kirsten L Johansen
Journal:  J Ren Nutr       Date:  2018-03-29       Impact factor: 3.655

Review 2.  Phosphate balance in ESRD: diet, dialysis and binders against the low evident masked pool.

Authors:  A Galassi; A Cupisti; A Santoro; M Cozzolino
Journal:  J Nephrol       Date:  2014-09-23       Impact factor: 3.902

Review 3.  Bone-Muscle Mutual Interactions.

Authors:  Nuria Lara-Castillo; Mark L Johnson
Journal:  Curr Osteoporos Rep       Date:  2020-08       Impact factor: 5.096

Review 4.  Skeleton and glucose metabolism: a bone-pancreas loop.

Authors:  Maria Felicia Faienza; Vincenza Luce; Annamaria Ventura; Graziana Colaianni; Silvia Colucci; Luciano Cavallo; Maria Grano; Giacomina Brunetti
Journal:  Int J Endocrinol       Date:  2015-03-19       Impact factor: 3.257

5.  Toward improved phosphorus efficiency in monogastrics-interplay of serum, minerals, bone, and immune system after divergent dietary phosphorus supply in swine.

Authors:  Michael Oster; Franziska Just; Kirsten Büsing; Petra Wolf; Christian Polley; Brigitte Vollmar; Eduard Muráni; Siriluck Ponsuksili; Klaus Wimmers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-03-09       Impact factor: 3.619

Review 6.  Mechanisms of altered bone remodeling in children with type 1 diabetes.

Authors:  Giacomina Brunetti; Gabriele D'Amato; Stefania De Santis; Maria Grano; Maria Felicia Faienza
Journal:  World J Diabetes       Date:  2021-07-15

7.  Higher daily physical activity is associated with higher osteocalcin levels in adolescents.

Authors:  Saydi E Chahla; Brigitte I Frohnert; William Thomas; Aaron S Kelly; Brandon M Nathan; Lynda E Polgreen
Journal:  Prev Med Rep       Date:  2015

8.  Therapeutic management of hypophosphatemic rickets from infancy to adulthood.

Authors:  Agnès Linglart; Martin Biosse-Duplan; Karine Briot; Catherine Chaussain; Laure Esterle; Séverine Guillaume-Czitrom; Peter Kamenicky; Jerome Nevoux; Dominique Prié; Anya Rothenbuhler; Philippe Wicart; Pol Harvengt
Journal:  Endocr Connect       Date:  2014-03-14       Impact factor: 3.335

Review 9.  The sound of health.

Authors:  Giamila Fantuzzi
Journal:  Front Immunol       Date:  2014-07-21       Impact factor: 7.561

10.  Serum Osteocalcin Is Associated with Inflammatory Factors in Metabolic Syndrome: A Population-Based Study in Chinese Males.

Authors:  Ming Liao; Lirong Huang; Yan Mao; Yonghua Jiang; Ziting Yao; Xinggu Lin; Zheng Lu; Chunlei Wu; Xue Qin; Haiying Zhang; Zengnan Mo
Journal:  Mediators Inflamm       Date:  2015-10-22       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.